Page 668

(31) Respiratory syncytial virus (RSV);

(32) Salmonella;

(33) SARS-CoV-2;

(34) Shigella species;

(35) Streptococcus agalactiae from normally sterile body fluid or site;

(36) Streptococcus pneumoniae from normally sterile body fluid or site;

(37) Streptococcus pyogenes from normally sterile body fluid or site;

(38) Taenia species;

(39) Treponema pallidum;

(40) Trichinella species;

(41) varicella virus, when associated with a death;

(42) Vibrio species;

(43) Yersinia enterocolitica or Yersinia pseudotuberculosis. (c) Each report must give

(1) the date and result of the examination or test performed;

(2) the name or identification code sufficient to identify the patient to the health care provider; and

(3) the date of birth, address and telephone number, sex, race, and ethnicity of the patient from whom the specimen was obtained and the name and address of the health care provider for whom the examination or test was performed. (d) When acting on the basis of information received from a report made under this section, the public health agent shall first attempt to contact the health care provider for whom the examination or test was performed before contacting the patient directly. (e) A laboratory that confirms one of the pathogens in the following list shall submit isolates or aliquots of original specimens to the state public health laboratory:

(1) antibiotic-resistant organisms of national significance, including Candida auris and carbapenem-resistant organisms;

(2) Bacillus anthracis;

(3) Brucella species;

(4) Burkholderia mallei;